Secretome profile analysis of hypervirulent Mycobacterium tuberculosis CPT31 reveals increased production of EsxB and proteins involved in adaptation to intracellular lifestyle
- PMID: 26733498
- DOI: 10.1093/femspd/ftv127
Secretome profile analysis of hypervirulent Mycobacterium tuberculosis CPT31 reveals increased production of EsxB and proteins involved in adaptation to intracellular lifestyle
Abstract
Epidemiological information and animal models have shown various Mycobacterium tuberculosis phenotypes ranging from hyper- to hypovirulent forms. Recent genomic and proteomic studies suggest that the outcome of infection depends on the M. tuberculosis fitness, which is a direct consequence of its phenotype. However, little is known about the molecular and cellular mechanisms used by mycobacteria to survive, replicate and persist during infection. The aim of this study was to perform a comprehensive proteomic analysis of culture filtrate from hypo- (CPT23) and hypervirulent (CPT31) M. tuberculosis isolates. Using two-dimensional electrophoresis we observed that 70 proteins were unique, or more abundant in culture filtrate of CPT31, and 15 of these were identified by mass spectrometry. Our analysis of protein expression showed that most of the proteins identified are involved in lipid metabolism (FadA3, FbpB and EchA3), detoxification and adaptation (GroEL2, SodB and HspX) and cell wall processes (LprA, Tig and EsxB). These results suggest that overrepresented proteins in M. tuberculosis CPT31 secretome could facilitate mycobacterial infection and persistence.
Keywords: Mycobacterium tuberculosis; hypervirulent; lifestyle; secretome profile.
© FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolates.Mol Cell Proteomics. 2010 Nov;9(11):2414-23. doi: 10.1074/mcp.M900422-MCP200. Epub 2010 Feb 26. Mol Cell Proteomics. 2010. PMID: 20190197 Free PMC article.
-
Secretome profiling of highly virulent Mycobacterium bovis 04-303 strain reveals higher abundance of virulence-associated proteins.Microb Pathog. 2016 Nov;100:305-311. doi: 10.1016/j.micpath.2016.10.014. Epub 2016 Oct 18. Microb Pathog. 2016. PMID: 27769937
-
Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate.PLoS One. 2020 Mar 3;15(3):e0221837. doi: 10.1371/journal.pone.0221837. eCollection 2020. PLoS One. 2020. PMID: 32126063 Free PMC article.
-
Mycobacterial proteomics: analysis of expressed proteomes and post-translational modifications to identify candidate virulence factors.Expert Rev Proteomics. 2015 Feb;12(1):21-35. doi: 10.1586/14789450.2015.1007046. Expert Rev Proteomics. 2015. PMID: 25603863 Review.
-
What Can Proteomics Tell Us about Tuberculosis?J Microbiol Biotechnol. 2015 Aug;25(8):1181-94. doi: 10.4014/jmb.1502.02008. J Microbiol Biotechnol. 2015. PMID: 25737117 Review.
Cited by
-
Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune Response.Cell Rep. 2019 Mar 26;26(13):3574-3585.e3. doi: 10.1016/j.celrep.2019.02.109. Cell Rep. 2019. PMID: 30917313 Free PMC article.
-
In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis.Comput Struct Biotechnol J. 2023 Jan 16;21:991-1004. doi: 10.1016/j.csbj.2023.01.019. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36733703 Free PMC article.
-
Sharpening Host Defenses during Infection: Proteases Cut to the Chase.Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S161-S171. doi: 10.1074/mcp.O116.066456. Epub 2017 Feb 8. Mol Cell Proteomics. 2017. PMID: 28179412 Free PMC article. Review.
-
Mycobacterium tuberculosis Cpn60.2 (GroEL2) blocks macrophage apoptosis via interaction with mitochondrial mortalin.Biol Open. 2017 Apr 15;6(4):481-488. doi: 10.1242/bio.023119. Biol Open. 2017. PMID: 28288970 Free PMC article.
-
Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS.Front Microbiol. 2016 Nov 15;7:1816. doi: 10.3389/fmicb.2016.01816. eCollection 2016. Front Microbiol. 2016. PMID: 27895634 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical